Gam Holding Ag Tcr2 Therapeutics Inc. Transaction History

Gam Holding Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$8.44 - $18.35 $492,414 - $1.07 Million	-58,343 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$20.38 - $34.07 $1.19 Million - $1.99 Million	58,343 New	58,343 $1.29 Million
Q4 2020 Feb 10, 2021	SELL	$19.0 - $32.63 $3.17 Million - $5.44 Million	-166,600 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$13.1 - $20.69 $1.89 Million - $2.99 Million	144,600 Added 657.27%	166,600 $3.39 Million
Q2 2020 Aug 10, 2020	BUY	$6.51 - $16.85 $143,220 - $370,700	22,000 New	22,000 $338,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.